Antidepressants and suicide

doi:10.1136/bmj.311.6996.55

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Ian Whyte,
Nick Buckley,
Greg Carter

Senior staff specialist Senior lecturer Senior staff specialist Department of Clinical Toxicology and Pharmacology, Hunter Area Health Service, Newcastle Mater Misericordiae Hospital, Locked Bag 7, Hunter Regional Mail Centre, NSW 2310, Australia

Study analyses were flawed

EDITOR,--Two recent articles look at use of antidepressants and death from suicide. John A Henry and colleagues have continued previous work and assessed the relation between death and defined daily dose.1 Unfortunately, the defined daily dose for dothiepin used in the paper (75 mg) should be 150 mg (references quoted by Henry and colleagues). The correct figure is then 3.08 deaths per million defined daily doses of dothiepin instead of 1.54--the second highest figure, after that for amoxapine. This agrees with a clinical study that …